200 related articles for article (PubMed ID: 34215742)
1. Reduced efficacy of a Src kinase inhibitor in crowded protein solution.
Kasahara K; Re S; Nawrocki G; Oshima H; Mishima-Tsumagari C; Miyata-Yabuki Y; Kukimoto-Niino M; Yu I; Shirouzu M; Feig M; Sugita Y
Nat Commun; 2021 Jul; 12(1):4099. PubMed ID: 34215742
[TBL] [Abstract][Full Text] [Related]
2. Pyrazolo pyrimidine-type inhibitors of SRC family tyrosine kinases promote ovarian steroid-induced differentiation of human endometrial stromal cells in vitro.
Maruyama T; Yamamoto Y; Shimizu A; Masuda H; Sakai N; Sakurai R; Asada H; Yoshimura Y
Biol Reprod; 2004 Jan; 70(1):214-21. PubMed ID: 14522827
[TBL] [Abstract][Full Text] [Related]
3. The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases.
Tatton L; Morley GM; Chopra R; Khwaja A
J Biol Chem; 2003 Feb; 278(7):4847-53. PubMed ID: 12475982
[TBL] [Abstract][Full Text] [Related]
4. Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastoma.
Tintori C; Fallacara AL; Radi M; Zamperini C; Dreassi E; Crespan E; Maga G; Schenone S; Musumeci F; Brullo C; Richters A; Gasparrini F; Angelucci A; Festuccia C; Delle Monache S; Rauh D; Botta M
J Med Chem; 2015 Jan; 58(1):347-61. PubMed ID: 25469771
[TBL] [Abstract][Full Text] [Related]
5. Src family-selective tyrosine kinase inhibitor, PP1, inhibits both Fc epsilonRI- and Thy-1-mediated activation of rat basophilic leukemia cells.
Amoui M; Dráber P; Dráberová L
Eur J Immunol; 1997 Aug; 27(8):1881-6. PubMed ID: 9295022
[TBL] [Abstract][Full Text] [Related]
6. Protein kinases and adherens junction dynamics in the seminiferous epithelium of the rat testis.
Lee NP; Cheng CY
J Cell Physiol; 2005 Feb; 202(2):344-60. PubMed ID: 15389520
[TBL] [Abstract][Full Text] [Related]
7. Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck.
Zhou HR; Jia Q; Pestka JJ
Toxicol Sci; 2005 Jun; 85(2):916-26. PubMed ID: 15772366
[TBL] [Abstract][Full Text] [Related]
8. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for selective inhibition of Src family kinases by PP1.
Liu Y; Bishop A; Witucki L; Kraybill B; Shimizu E; Tsien J; Ubersax J; Blethrow J; Morgan DO; Shokat KM
Chem Biol; 1999 Sep; 6(9):671-8. PubMed ID: 10467133
[TBL] [Abstract][Full Text] [Related]
10. The Src-family tyrosine kinase inhibitor PP1 interferes with the activation of ribosomal protein S6 kinases.
Shah OJ; Kimball SR; Jefferson LS
Biochem J; 2002 Aug; 366(Pt 1):57-62. PubMed ID: 12014987
[TBL] [Abstract][Full Text] [Related]
11. Irreversible inhibitors of c-Src kinase that target a nonconserved cysteine.
Kwarcinski FE; Fox CC; Steffey ME; Soellner MB
ACS Chem Biol; 2012 Nov; 7(11):1910-7. PubMed ID: 22928736
[TBL] [Abstract][Full Text] [Related]
12. Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases.
Warmuth M; Simon N; Mitina O; Mathes R; Fabbro D; Manley PW; Buchdunger E; Forster K; Moarefi I; Hallek M
Blood; 2003 Jan; 101(2):664-72. PubMed ID: 12393636
[TBL] [Abstract][Full Text] [Related]
13. Voltage-independent inhibition of P/Q-type Ca2+ channels in adrenal chromaffin cells via a neuronal Ca2+ sensor-1-dependent pathway involves Src family tyrosine kinase.
Weiss JL; Burgoyne RD
J Biol Chem; 2001 Nov; 276(48):44804-11. PubMed ID: 11583988
[TBL] [Abstract][Full Text] [Related]
14. Src family kinase inhibitor PP1 reduces secondary damage after spinal cord compression in rats.
Akiyama C; Yuguchi T; Nishio M; Tomishima T; Fujinaka T; Taniguchi M; Nakajima Y; Kohmura E; Yoshimine T
J Neurotrauma; 2004 Jul; 21(7):923-31. PubMed ID: 15307904
[TBL] [Abstract][Full Text] [Related]
15. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
[TBL] [Abstract][Full Text] [Related]
16. Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment.
Molinari A; Fallacara AL; Di Maria S; Zamperini C; Poggialini F; Musumeci F; Schenone S; Angelucci A; Colapietro A; Crespan E; Kissova M; Maga G; Botta M
Bioorg Med Chem Lett; 2018 Nov; 28(21):3454-3457. PubMed ID: 30262428
[TBL] [Abstract][Full Text] [Related]
17. Bivalent Inhibitors of c-Src Tyrosine Kinase That Bind a Regulatory Domain.
Johnson TK; Soellner MB
Bioconjug Chem; 2016 Jul; 27(7):1745-9. PubMed ID: 27266260
[TBL] [Abstract][Full Text] [Related]
18. c-Src and Pyk2 protein tyrosine kinases play protective roles in early HIV-1 infection of CD4+ T-cell lines.
McCarthy SD; Jung D; Sakac D; Branch DR
J Acquir Immune Defic Syndr; 2014 Jun; 66(2):118-26. PubMed ID: 24413044
[TBL] [Abstract][Full Text] [Related]
19. The tyrosine kinase c-Src is required for 1,25(OH)2-vitamin D3 signalling to the nucleus in muscle cells.
Buitrago C; Boland R; de Boland AR
Biochim Biophys Acta; 2001 Dec; 1541(3):179-87. PubMed ID: 11755212
[TBL] [Abstract][Full Text] [Related]
20. Src-family kinase-p53/ Lyn p56 plays an important role in TNF-alpha-stimulated production of O2- by human neutrophils adherent to fibrinogen.
Yan SR; Novak MJ
Inflammation; 1999 Apr; 23(2):167-78. PubMed ID: 10213272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
